Subscribe To
Roivant, pfizer shares rise as roche agrees to buy immunology company for $7.1 billion
Shares of Roivant Sciences Ltd. ROIV, -1.13% and Pfizer Inc. PFE, -1.73% gained ground premarket on Monday after Roche Holding AG ...
October 23, 2023, 8:36 am
Roche (rhhby) nine months’ sales fall on lower covid-19 test sale
Roche’s rhhby performance in the third quarter and the first nine months of 2023 was impacted by a sh...
October 21, 2023, 1:59 am
Roche reports nine months sales growth despite lower sales from covid-19 products
Roche Holdings AG’s rhhby nine months sales increased by 1% (down 6% in CHF) to CHF 44.1 billion, eve...
October 19, 2023, 1:44 pm
Roche (rhhby) nine months' sales fall on lower covid-19 test sale
Roche (rhhby) reports a sales decline in the first nine months of 2023 as COVID-19-test sales continue ...
October 19, 2023, 12:47 pm
Roche's (rhhby) ms drug reduces brain lesions in phase ii study
Roche (rhhby) presents new data from a phase II study, which shows that fenebrutinib is brain penetrant...
October 16, 2023, 2:17 pm
Roche's (rhhby) vabysmo positive in late-stage rvo studies
Roche (rhhby) Vabysmo maintains vision improvements with extended treatment intervals of up to four mon...
October 10, 2023, 1:32 pm
Genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
October 2, 2023, 1:00 am
Roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd
Basel, 02 October 2023 - Roche (SIX: RO, ROG; OTCQX: rhhby) will present new data for OCREVUS® (ocreli...
October 2, 2023, 1:00 am
Roche's (rhhby) application for pnh drug accepted by fda
Roche (rhhby) biologics license application seeking approval for crovalimab for paroxysmal nocturnal he...
September 6, 2023, 10:32 am
Roche's (rhhby) late-stage lung cancer study meets primary goal
Roche's (rhhby) late-stage ALK-positive non-small cell lung cancer study evaluating Alecensa meets the ...
September 1, 2023, 9:47 am
Roche's (rhhby) evrysdi gets label expansion in eu for newborns
Following the label expansion, Roche's (rhhby) Evrysdi is now approved to treat people of all ages with...
August 29, 2023, 12:46 pm
Biotech stocks rally after roche's (rhhby) accidental data leak
Shares of several companies developing anti-TIGIT therapies rise after Roche (rhhby) accidentally leaks...
August 24, 2023, 12:47 pm
Gilead, arcus, iteos, other biopharmas get boost from accidental disclosure of roche lung cancer trial data
Shares of biopharmaceutical companies developing anti-TIGIT cancer therapies, including Gilead Sciences Inc. GILD, +0.54%, Arcus Biosciences Inc. RCUS...
August 23, 2023, 8:45 am
Roche (rhhby) 1h revenues, earnings down on lower covid-19 test sales
Image Source: Zacks Investment Research The company reported total sales of CHF 14.4 billion in the second quarter of 2023, flat year over year. Sales...
July 27, 2023, 5:59 pm
Roche’s 1h earnings decline on lower covid-19 sales, cfo says late-stage pipeline has gaps that needs to be filled
Roche Holding AG (OTC: rhhby) said sales for 1H 2023 dropped to CHF 30.62 billion from CHF 33.9 billion...
July 27, 2023, 3:59 pm
Roche holding ag (rhhby) q2 2023 earnings call transcript
Roche Holding AG (OTCQX:rhhby) Q2 2023 Earnings Conference Call July 27, 2023 8:00 AM ET Company Partic...
July 27, 2023, 3:55 pm
Roche (rhhby) 1h revenues, earnings down on lower covid-19 test sales
Roche's (rhhby) performance in the first half of 2023 was ordinary as COVID-19-test sales continue to d...
July 27, 2023, 1:57 pm
Roivant (roiv) up on reports of colitis drug sale to roche
Shares of Roivant ROIV rose almost 12% on Thursday after a Wall Street Journal (WSJ) article reported that Roche ...
July 14, 2023, 12:39 pm
Roche (rhhby) blood cancer drug columvi wins ec approval
Roche's (rhhby) blood cancer portfolio gets a boost with the EC's approval of Columvi (glofitamab-gxbm)...
July 11, 2023, 2:02 pm
Roche (rhhby) announces positive long-term data on sma drug
Roche's (rhhby) SMA drug Evrysdi maintains its efficacy and safety profile in children with type 1 SMA ...
July 3, 2023, 12:57 pm